U.S. FDA halts sales of Juul e-cigarettes Therapeutics The Food and Drug Administration on Thursday blocked e-cigarette maker Juul Labs Inc. from selling its nicotine products in the United States, potentially dealing a fatal blow to the once high-flying San Francisco company. Read more June 23, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersJuul6-23-2022.webp 857 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-06-23 10:59:452022-06-23 11:30:28U.S. FDA halts sales of Juul e-cigarettes